Skip to main content
. Author manuscript; available in PMC: 2020 Jul 21.
Published in final edited form as: J Urol. 2019 Jul 8;202(2):333–338. doi: 10.1097/JU.0000000000000223

Table 3.

Odds ratios* (95% confidence intervals) for having an outpatient visit for urinary incontinence,

OR (95% CI) P-value
UI Severity
Slight 1.00 Reference
Moderate 1.99 (1.64-2.42) <.001
Severe 3.75 (3.10-4.53) <.001
UI Type
Stress 1.00 Reference
Urgency 1.80 (1.56-2.08) <.001
Mixed 1.75 (1.51-2.03) <.001
Other 1.56 (1.27-1.91) <.001
Age Category
65-75 1.00 Reference
76-85 1.03 (0.93-1.15) 0.48
>85 1.01 (0.86-1.18) 0.77
White Race 0.93 (0.63-1.36) 0.74
BMI Category
< 25 1.00 Reference
≥25 to < 30 0.98 (0.88-1.09) 0.73
≥30 to <40 0.96 (0.85-1.09) 0.55
≥40 0.76 (0.57-1.01) 0.07
Parity
0 1.00 Reference
1 0.82 (0.61-1.09) 0.16
≥2 1.00 (0.81-1.24) 0.97
Current Smoker 0.74 (0.57-0.96) 0.02
Post-menopausal hormone therapy in past 2 years 1.94 (1.71-2.20) <.001
Report of seeking preventative health screening in the last 2 years 1.60 (0.76-3.36) 0.22
Prior Hysterectomy 1.15 (1.05-1.26) 0.004
Elixhauser Medical Comorbidity
0 1.00 Reference
1-2 1.31 (1.16-1.48) <.001
≥3 1.43 (1.24-1.65) <.001
Instrumental disability with ≥1 instrumental ADLs 1.12 (1.01-1.25) 0.01
SF-36 Physical Function Score ≤80 0.98 (0.87-1.10) 0.73
Census Region
Northeast 1.00 Reference
South 1.07 (0.96-1.20) 0.77
Midwest 0.80 (0.69-0.92) 0.002
West 1.04 (0.90-1.20) 0.21
Census Tract Median Income Level ($)
Tertile 1 1.00 Reference
Tertile 2 1.09 (0.97-1.22) 0.13
Tertile 3 1.10 (0.98-1.23) 0.12

OR: odds ratio; CI: confidence interval; ADL: activities of daily living; SF-36: Medical Outcomes Short Form-36; UI: urinary incontinence

*

Adjusted for all variables included in the table and whether the participant died during follow-up, UI severity (slight, moderate, severe), UI type (stress, urgency, mixed, other). age (65-75, 76-85, >85), White race, census region (Northeast, South, Midwest, West), Census tract median income level (tertiles), smoking status, BMI (<25, ≥25 to <30, ≥30 to <40, ≥40 kg/m2), parity (0, 1, ≥2), post-menopausal hormone therapy in past 2 years, report of seeking preventative health screening in the last 2 years (includes physical exam, eye exam, mammogram or colonoscopy), prior hysterectomy, Elixhauser medical comorbidity (0, 1-2, ≥3), instrumental disability with ≥1 instrumental ADLs, SF-36 physical function score (<80, ≥80),

Preventative health screenings include physical exam, eye exam, mammogram or colonoscopy.